Telangana issues recall for Azima-500 LB tablets over quality concerns

The Telangana Drug Control Administration and TG SAFE have recalled a specific batch of Azima-500 LB tablets after it was declared Not of Standard Quality. Authorities advised the public not to consume the affected batch and directed chemists to withdraw stocks.

Hyderabad: The Telangana Drug Control Administration (TGDCA) and TG SAFE on Wednesday issued an urgent drug recall and public advisory warning the public not to consume a specific batch of Azithromycin and Lactic Acid Bacillus Tablets, marketed as Azima-500 LB.

The affected product, batch number GT30389J, has been declared “Not of Standard Quality” (NSQ) after being tested at the Central Drugs Laboratory in Kolkata, the TGDCA said. The recalled tablets were manufactured by J.M. Laboratories, Village Bhanat, Solan (HP), with a manufacturing date of 12/2025 and an expiry date of 11/2027.

---

The drug regulatory authorities have advised the public against using this medication and recommended that patients consult their doctor or pharmacist for safe alternatives. Instructions were issued to chemists and stockists to immediately withdraw the defective batch from distribution and sale. Trade members were also required to report any available stock of this specific batch to their nearest Drugs Inspector Office under TG SAFE, the advisory added.

Azima-500 LB is a combination drug containing the broad-spectrum antibiotic Azithromycin and Lactic Acid Bacillus, which is a probiotic. The medicine is usually prescribed for a wide variety of medical conditions, including bronchitis, pneumonia, tonsillitis, ear, nose and throat infections, and skin and soft tissue infections.